Hyperemesis Gravidarum: A Review of Recent Literature

被引:89
作者
London, Viktoriya [1 ]
Grube, Stephanie [1 ]
Sherer, David M. [1 ]
Abulafia, Ovadia [1 ]
机构
[1] Suny Downstate Med Ctr, Div Maternal Fetal Med, Dept Obstet & Gynecol, 450 Clarkson Ave,Box 24, Brooklyn, NY 11203 USA
关键词
Hyperemesis gravidarum; Nausea and vomiting of pregnancy; Therapeutic modalities; WERNICKES ENCEPHALOPATHY; MATERNAL EXPOSURE; PREGNANCY; NAUSEA; RISK; METOCLOPRAMIDE; ONDANSETRON; MIRTAZAPINE; DEPRESSION; CORTICOSTEROIDS;
D O I
10.1159/000477853
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: In the United States, hyperemesis gravidarum is the most common cause of hospitalization during the first half of pregnancy and is second only to preterm labor for hospitalizations in pregnancy overall. In approximately 0.3-3% of pregnancies, hyperemesis gravidarum is prevalent and this percentage varies on account of different diagnostic criteria and ethnic variation in study populations. Despite extensive research in this field, the mechanism of the disease is largely unknown. Although cases of mortality are rare, hyperemesis gravidarum has been associated with both maternal and fetal morbidity. The current mainstay of treatment relies heavily on supportive measures until improvement of symptoms as part of the natural course of hyperemesis gravidarum, which occurs with progression of gestational age. However, studies have reported that severe, refractory disease manifestations have led to serious adverse outcomes and to termination of pregnancies. Summary: Despite extensive research in the field, the pathogenesis of hyperemesis gravidarum remains unknown. Recent literature points to a genetic predisposition in addition to previously studied factors such as infectious, psychiatric, and hormonal contributions. Maternal morbidity is common and includes psychological effects, financial burden, clinical complications from nutritional deficiencies, gastrointestinal trauma, and in rare cases, neurological damage. The effect of hyperemesis gravidarum on neonatal health is still debated in literature with conflicting results regarding outcomes of birth weight and prematurity. Available therapy options remain largely unchanged in the past several decades and focus on parenteral antiemetic medications, electrolyte repletion, and nutritional support. Most studies of therapeutic options do not consist of randomized control studies and cross-study analysis is difficult due to considerable variation of diagnostic criteria. Key Messages: Hyperemesis gravidarum carries a significant burden on maternal health and US health care. Most published research on pathogenesis is observational and suggests multifactorial associations with hyperemesis gravidarum. Precise, strictly defined criteria for clinical diagnosis are likely to benefit meta-analyses of further research studies regarding pathogenesis as well as therapeutic options. (C) 2017 S. Karger AG, Basel
引用
收藏
页码:161 / 171
页数:11
相关论文
共 50 条
  • [21] Change in paternity and recurrence of hyperemesis gravidarum
    Fejzo, Marlena S.
    Ching, ChunYu
    Schoenberg, Frederic P.
    Macgibbon, Kimber
    Romero, Roberto
    Goodwin, T. Murphy
    Mullin, Patrick M.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2012, 25 (08) : 1241 - 1245
  • [22] Nutritional consequences and management of hyperemesis gravidarum: a narrative review
    Maslin, Kate
    Dean, Caitlin
    NUTRITION RESEARCH REVIEWS, 2022, 35 (02) : 308 - 318
  • [23] Is Prednisolone Useful in Treatment of Hyperemesis Gravidarum?
    Asmat, Aroosha
    Yasin, Iqra
    Hamid, Iffat
    Nawaz, Riffat
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [24] Psychiatric consultation of patients with hyperemesis gravidarum
    Kim, Deborah R.
    Connolly, K. R.
    Cristancho, Pilar
    Zappone, Mark
    Weinrieb, Robert M.
    ARCHIVES OF WOMENS MENTAL HEALTH, 2009, 12 (02) : 61 - 67
  • [25] Wernicke's encephalopathy in women with hyperemesis gravidarum - Case series and literature review
    Rane, Makarand Anil
    Boorugu, Hari Kishan
    Ravishankar, Usha
    Tarakeswari, S.
    Vadlamani, Hemamalini
    Anand, Hemalatha
    TROPICAL DOCTOR, 2022, 52 (01) : 98 - 100
  • [26] Hyperemesis gravidarum
    Yeh, Chang-Ching
    Tsui, Kuan-Hao
    Wang, Peng-Hui
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (09) : 755 - 756
  • [27] Polyunsaturated Fatty Acids and Their Metabolites in Hyperemesis Gravidarum
    Lindberg, Richard
    Lindqvist, Maria
    Trupp, Miles
    Vinnars, Marie-Therese
    Nording, Malin L.
    NUTRIENTS, 2020, 12 (11) : 1 - 14
  • [28] Determinants of disease course and severity in hyperemesis gravidarum
    Koot, Marjette H.
    Grooten, Iris J.
    van der Post, Joris A. M.
    Bais, Joke M. J.
    Ris-Stalpers, Carrie
    Leeflang, Mariska M. G.
    Bremer, Henk A.
    van der Ham, David P.
    Heidema, Wieteke M.
    Huisjes, Anjoke
    Kleiverda, Gunilla
    Kuppens, Simone M.
    van Laar, Judith O. E. H.
    Langenveld, Josje
    van der Made, Flip
    van Pampus, Marielle G.
    Papatsonis, Dimitri
    Pelinck, Marie-Jose
    Pernet, Paula J.
    van Rheenen-Flach, Leonie
    Rijnders, Robbert J.
    Scheepers, Hubertina C. J.
    Vogelvang, Tatjana E.
    Mol, Ben W.
    Roseboom, Tessa J.
    Painter, Rebecca C.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 245 : 162 - 167
  • [29] Predictive factors of Hyperemesis Gravidarum: A systematic review
    Ioannidou, Pinelopi
    Papanikolaou, Dimitrios
    Mikos, Themistoklis
    Mastorakos, George
    Goulis, Dimitrios G.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2019, 238 : 178 - 187
  • [30] The clinical management of hyperemesis gravidarum
    Sonkusare, Shipra
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (06) : 1183 - 1192